NASDAQ:OM Outset Medical (OM) Stock Price, News & Analysis $3.74 +0.03 (+0.81%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$3.65▼$3.8350-Day Range$3.54▼$4.8252-Week Range$1.92▼$20.75Volume347,792 shsAverage Volume1.13 million shsMarket Capitalization$193.43 millionP/E RatioN/ADividend YieldN/APrice Target$5.42 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Outset Medical alerts: Email Address Outset Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside44.8% Upside$5.42 Price TargetShort InterestHealthy14.68% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.69Based on 4 Articles This WeekInsider TradingSelling Shares$220,830 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.23) to ($1.73) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.94 out of 5 starsMedical Sector653rd out of 936 stocksElectromedical Equipment Industry15th out of 22 stocks 3.3 Analyst's Opinion Consensus RatingOutset Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageOutset Medical has only been the subject of 1 research reports in the past 90 days.Read more about Outset Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted14.68% of the outstanding shares of Outset Medical have been sold short.Short Interest Ratio / Days to CoverOutset Medical has a short interest ratio ("days to cover") of 6.1.Change versus previous monthShort interest in Outset Medical has recently decreased by 11.33%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldOutset Medical does not currently pay a dividend.Dividend GrowthOutset Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OM. Previous Next 2.6 News and Social Media Coverage News SentimentOutset Medical has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Outset Medical this week, compared to 2 articles on an average week.Search Interest4 people have searched for OM on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $220,830.00 in company stock.Percentage Held by InsidersOnly 3.50% of the stock of Outset Medical is held by insiders.Read more about Outset Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Outset Medical are expected to grow in the coming year, from ($2.23) to ($1.73) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Outset Medical is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Outset Medical is -1.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOutset Medical has a P/B Ratio of 1.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Outset Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Outset Medical Stock (NASDAQ:OM)Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Read More OM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OM Stock News HeadlinesJuly 26 at 6:27 AM | msn.comGoogle is updating the Play Store with AI-powered app reviews and curated spacesJuly 1, 2024 | investorplace.com3 MedTech Stocks to Buy for Healthy GainsJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 12, 2024 | finance.yahoo.comAnalysts Are Updating Their Outset Medical, Inc. (NASDAQ:OM) Estimates After Its First-Quarter ResultsMay 10, 2024 | finance.yahoo.comOutset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens LossesMay 9, 2024 | markets.businessinsider.comRBC Capital Keeps Their Hold Rating on Outset Medical (OM)May 9, 2024 | finance.yahoo.comOutset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finance.yahoo.comOutset Medical Inc (OM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 9, 2024 | finance.yahoo.comOutset Medical First Quarter 2024 Earnings: US$0.79 loss per share (vs US$0.90 loss in 1Q 2023)May 8, 2024 | finance.yahoo.comOutset Medical Reports First Quarter 2024 Financial ResultsMay 8, 2024 | msn.comOutset Medical Non-GAAP EPS of -$0.57 misses by $0.02, revenue of $28.2M misses by $2.15MMay 8, 2024 | msn.comOM Stock Earnings: Outset Medical Misses EPS, Misses Revenue for Q1 2024May 6, 2024 | marketwatch.comOutset Medical Shares Rise 56% After FDA Grants Clearance for TabloCartMay 6, 2024 | msn.comWhy Outset Medical Shares Are Up TodayMay 6, 2024 | msn.comOutset Medical stock rallies 40% on FDA clearance of dialysis deviceMay 6, 2024 | markets.businessinsider.comWhy Outset Medical Is Rising In Pre-market?May 6, 2024 | businesswire.comOutset Medical's TabloCart with Prefiltration Receives FDA 510(k) ClearanceSee More Headlines Receive OM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today7/26/2024Next Earnings (Confirmed)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:OM CUSIPN/A CIK1484612 Weboutsetmedical.com Phone669-231-8200FaxN/AEmployees520Year FoundedN/APrice Target and Rating Average Stock Price Target$5.42 High Stock Price Target$6.00 Low Stock Price Target$3.00 Potential Upside/Downside+46.0%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-172,800,000.00 Net Margins-134.93% Pretax Margin-134.54% Return on Equity-120.67% Return on Assets-51.09% Debt Debt-to-Equity Ratio2.11 Current Ratio6.42 Quick Ratio5.32 Sales & Book Value Annual Sales$130.38 million Price / Sales1.47 Cash FlowN/A Price / Cash FlowN/A Book Value$2.45 per share Price / Book1.51Miscellaneous Outstanding Shares51,720,000Free Float49,912,000Market Cap$191.88 million OptionableNot Optionable Beta2.00 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMs. Leslie L. Trigg (Age 53)President, CEO & Chairman Comp: $1.22MMr. Nabeel Ahmed (Age 48)Chief Financial Officer Comp: $654.74kMr. John L. Brottem (Age 49)General Counsel & Secretary Comp: $594.15kMr. Marc Nash (Age 35)Senior Vice President of Operations and R&D Mr. Jean-Olivier Racine (Age 42)Chief Technology Officer Comp: $540.93kMr. James S. MazzolaHead of Investor RelationsNicole ShannonDirector of Marketing CommunicationsDr. Michael Aragon M.D.Chief Medical OfficerMr. Mark Gordon M.S. (Age 67)Chief Regulatory & Quality Officer More ExecutivesKey CompetitorsPerspective TherapeuticsNYSE:CATXOrthoPediatricsNASDAQ:KIDSSI-BONENASDAQ:SIBNIradimedNASDAQ:IRMDTreace Medical ConceptsNASDAQ:TMCIView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpSold 276,155 shares on 7/26/2024Ownership: 0.958%Summit Securities Group LLCBought 27,174 shares on 7/26/2024Ownership: 0.053%Marc NashSold 723 sharesTotal: $2,906.46 ($4.02/share)Griffin Asset Management Inc.Bought 7,600 shares on 7/23/2024Ownership: 0.204%Assenagon Asset Management S.A.Bought 570,281 shares on 7/18/2024Ownership: 2.929%View All Insider TransactionsView All Institutional Transactions OM Stock Analysis - Frequently Asked Questions How have OM shares performed this year? Outset Medical's stock was trading at $5.41 on January 1st, 2024. Since then, OM shares have decreased by 30.9% and is now trading at $3.74. View the best growth stocks for 2024 here. How were Outset Medical's earnings last quarter? Outset Medical, Inc. (NASDAQ:OM) released its quarterly earnings data on Wednesday, May, 8th. The company reported ($0.73) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by $0.13. The firm had revenue of $28.17 million for the quarter, compared to analysts' expectations of $30.55 million. Outset Medical had a negative trailing twelve-month return on equity of 120.67% and a negative net margin of 134.93%. When did Outset Medical IPO? Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Outset Medical's major shareholders? Top institutional shareholders of Outset Medical include Assenagon Asset Management S.A. (2.93%), Bank of New York Mellon Corp (0.96%), Griffin Asset Management Inc. (0.20%) and Summit Securities Group LLC (0.05%). Insiders that own company stock include Leslie Trigg, Steven S Williamson, Nabeel Ahmed, Jean-Olivier Racine, John L Brottem, Marc Nash, Martin Vazquez, Stacey L Porter and D Keith Grossman. View institutional ownership trends. How do I buy shares of Outset Medical? Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OM) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outset Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
